CPT® Code 80050

Last Updated: February 2026 | Verified for 2026 AMA, CPT & CMS Guidelines

Quick Reference: CPT 80050

• Definition: General Health Panel — a bundled laboratory panel that must include a Comprehensive Metabolic Panel (80053), a Complete Blood Count with differential (85025 or equivalent), and Thyroid Stimulating Hormone (84443).
• Panel Type: Organ or Disease-Oriented Panel (AMA CPT Section 80047–80081).
• Screening vs. Diagnostic: Use 80050 only when all three components are ordered together as a routine screening. Do not use when tests are ordered individually for a diagnostic purpose.
• Medicare Status: NOT covered by Medicare Traditional (Fee-for-Service). CMS removed 80050 from the Clinical Lab Fee Schedule due to overuse. Bill components separately: 80053, 85025, and 84443.
• Critical 2026 Alert: Several major commercial payers (including Health Net California, effective February 1, 2026) have ended coverage of 80050. Always verify payer-specific policies before billing.
• All-or-Nothing Rule: 80050 may only be reported when all required components are performed. If any component is missing, bill the individual codes that were actually performed.
• Do Not Double-Bill: Never bill 80050 alongside its component codes (80053, 85025, 84443) on the same date of service for the same patient. CPT 80050 — the General Health Panel — is one of the most frequently ordered and most frequently misunderstood laboratory panel codes in outpatient and preventive medicine billing. It bundles three comprehensive test groups into a single code and is typically ordered during annual wellness visits, pre-employment screenings, and routine health assessments.

However, the landscape for reimbursement is rapidly shifting: Medicare has long excluded this code from coverage, and in early 2026, major commercial insurers are following suit, requiring providers to submit component codes individually. Understanding the technical requirements, payer rules, and documentation standards for CPT 80050 is essential to avoid denials, audits, and compliance risk .

1. Official AMA Definition & Required Components

The American Medical Association (AMA) CPT manual defines CPT 80050 as follows:

“General health panel. This panel must include the following: Comprehensive metabolic panel (80053); Blood count, complete (CBC), automated and automated differential WBC count (85025 or 85027 and 85004) OR Blood count, complete (CBC), automated (85027) and appropriate manual differential WBC count (85007 or 85009); Thyroid stimulating hormone (TSH) (84443).”

This is a strict, non-negotiable definition. Every component must be performed and reported; there is no partial credit. The panel exists for coding convenience only — the AMA explicitly notes that panels “were developed for coding purposes only and should not be interpreted as clinical parameters.”

Required Components at a Glance

2. Deep Dive: Each Component Explained

Component 1: Comprehensive Metabolic Panel (CPT 80053)

The CMP is itself a bundled panel of 14 individual analytes. It assesses three organ systems simultaneously:

Kidney Function: Blood Urea Nitrogen (BUN) (84520) and Creatinine (82565). These markers identify renal impairment, dehydration, or nephrotoxic medication effects. An elevated creatinine may trigger follow-up testing.

Liver Function: Alanine Aminotransferase/ALT (84460), Aspartate Aminotransferase/AST (84450), Alkaline Phosphatase/ALP (84075), Total Bilirubin (82247), Albumin (82040), and Total Protein (84155). Abnormal liver enzymes can indicate hepatitis, fatty liver disease, or medication toxicity.

Electrolyte & Metabolic Balance: Sodium (84295), Potassium (84132), Chloride (82435), Carbon Dioxide/Bicarbonate (82374), Glucose (82947), and Total Calcium (82310). These values assess acid-base balance, hydration status, and glucose metabolism.

Important: CPT 80053 (CMP) must not be billed alongside CPT 80048 (Basic Metabolic Panel) on the same date of service for the same patient, as the BMP’s analytes are a subset of the CMP. Only the more comprehensive code (80053) should be reported.

Component 2: Complete Blood Count with Differential (CPT 85025 or equivalent)

The CBC with automated differential evaluates all three cell lines: red blood cells (assessing for anemia), white blood cells (assessing for infection, inflammation, or hematologic malignancy), and platelets (assessing for bleeding risk or clotting disorders). The “differential” portion provides a breakdown of the five WBC types (neutrophils, lymphocytes, monocytes, eosinophils, basophils).

The preferred single code is 85025 (CBC with automated differential). Alternatively, labs may report 85027 (CBC without differential) paired with 85004 (automated differential), 85007 (manual differential via blood smear), or 85009 (manual differential via buffy coat). Any of these combinations satisfy the 80050 panel requirement for the CBC component.

Component 3: Thyroid Stimulating Hormone (CPT 84443)

TSH is a pituitary hormone that regulates the thyroid gland. It is the gold-standard first-line screening test for thyroid disorders, detecting both hypothyroidism (elevated TSH) and hyperthyroidism (suppressed TSH). Including TSH in the General Health Panel reflects its importance in population-wide screening, particularly given the prevalence of undiagnosed thyroid disease, which affects an estimated 20 million Americans.

3. When to Use 80050 vs. Individual Component Codes

This is the most critical decision point in billing for this panel. The rules are straightforward but frequently violated.

Use CPT 80050 ONLY when:

All three components (CMP, CBC with differential, and TSH) were performed together, ordered simultaneously as a general screening panel, and the payer accepts the bundled panel code. The ordering physician must have requested the tests as a group for routine health assessment purposes — not for investigating a specific suspected diagnosis.

Do NOT use CPT 80050 when:

The physician ordered only one or two of the three components (even if all were performed on the same day). The tests were ordered for a specific diagnostic reason rather than routine screening (e.g., ordering TSH because the patient has symptoms of hypothyroidism). The payer does not accept 80050 (including all Medicare payers and an increasing number of commercial payers in 2026). A third-party lab performed one component while your office performed another — the entity performing the services is relevant to determining which codes to bill.

The “Partial Panel” Rule:

If fewer than all required components are performed, you must bill each individual component code separately. For example, if only the CMP and CBC were ordered (no TSH), bill 80053 and 85025 individually. Never bill 80050 and then add a missing component separately on the same claim — this is a common audit trigger.

4. Medicare Coverage Status & Non-Coverage Rules

Medicare Does NOT Cover CPT 80050. CPT code 80050 has been removed from the Medicare Clinical Laboratory Fee Schedule (CLFS). CMS eliminated coverage due to a documented pattern of overuse — the bundled panel code was routinely submitted on claims even when all included tests were not actually performed. As a result, Medicare will automatically deny any claim submitted with CPT 80050 as the primary laboratory code.

What to Do Instead (Medicare Billing)

For Medicare patients, always bill the individual component codes that were actually performed:

Medicare Wellness Visits and Lab Testing:

Labs ordered as part of Medicare’s Annual Wellness Visit (AWV, G0438/G0439) or the Initial Preventive Physical Examination (IPPE, G0402) are not automatically covered as part of the preventive benefit. Coverage for individual lab components ordered during an AWV is determined by medical necessity on a test-by-test basis. There is no Medicare benefit that covers a routine “general health panel” analogous to 80050 for standard fee-for-service beneficiaries.

Advance Beneficiary Notice (ABN) Requirement:

When ordering tests for Medicare patients that may not be covered (e.g., TSH ordered as routine screening without a documented thyroid-related diagnosis), providers must issue and have the patient sign an ABN (CMS-R-131) before the test is performed. This protects the provider from financial liability and allows the patient to make an informed decision. Failure to provide an ABN when required means the provider cannot bill the patient if Medicare denies the claim.

ESRD and Composite Rate Patients

For End Stage Renal Disease (ESRD) patients on the Prospective Payment System (PPS), labs are typically bundled into the composite rate. If a test does not affect ESRD management, append the AY modifier to indicate the test is unrelated to ESRD treatment. Without the AY modifier, the claim may be denied as bundled into the composite rate even if the test is truly separate.

5. Commercial Payer Landscape (2026 Updates)

The commercial payer environment for CPT 80050 has undergone significant changes, particularly in late 2025 and early 2026. Providers must verify payer-specific policies before submitting claims.

Health Net California (Effective February 1, 2026)

Health Net California issued a formal provider bulletin in late November 2025 stating that CPT code 80050 coverage ended January 31, 2026. Effective February 1, 2026, claims submitted with 80050 are automatically denied. Reason codes issued are: Explanation code 46 for Individual & Family Plans (Ambetter HMO/PPO) and Disallow reason code 49 for Employer Group Plans. Providers must now bill 80053, 85025 or 85027, and 84443 individually.

UnitedHealthcare

UnitedHealthcare’s Laboratory Services Reimbursement Policy recognizes the organ and disease-oriented panels (including 80050) as defined in the CPT book, but the panel code is only reimbursed when all components are reported together and when all components were performed. If individual component codes are submitted that together equal a panel, UHC may automatically bundle them into the panel code. Conversely, if the panel is submitted but not all components were performed, the panel will be denied. Providers should verify current policy in the UHC Provider Portal, as policies are updated quarterly.

Medicaid (State-Specific)

Medicaid coverage of 80050 is highly variable by state. North Carolina Medicaid, for example, terminated coverage of CPT 80050 effective retroactively to January 1, 2022, following Medicare’s lead. Providers in NC must bill 80053, 84443, and 85025 individually for Medicaid patients. Other states have similar restrictions. Always check your state’s Medicaid fee schedule before submitting 80050.

Blue Cross Blue Shield Plans

BCBS coverage varies significantly by state plan. Some plans cover 80050 under preventive benefit provisions paired with Z00.00 (encounter for general adult medical examination), while others deny it as not being a recognized preventive service under ACA mandates. A plan that covered 80050 in a prior year may not cover it in the current year due to annual policy updates. Always verify current BCBS plan-specific coverage before billing.

6. ICD-10 Diagnosis Codes & Linking Rules

The diagnosis code linked to CPT 80050 must support either a routine/preventive encounter (when the payer covers preventive screening) or a specific medical condition (when billing individual component codes for Medicare or payers that don’t cover the bundled panel).

Key Diagnosis Linking Rule:

When billing 80050, the linked diagnosis must support the screening nature of the panel. If the clinical documentation shows that one or more tests were ordered because of a specific complaint, symptom, or existing diagnosis, those tests are diagnostic — not screening — and must be billed individually with the appropriate diagnostic ICD-10 code. Mixing screening and diagnostic intent on a single 80050 claim is a common audit finding.

7. Modifier Usage (91, 59, QW, AY)

Modifier 91 – Repeat Clinical Diagnostic Laboratory Test

Append Modifier 91 when the same laboratory test must be repeated on the same patient on the same date of service to obtain subsequent test results — for example, serial glucose monitoring in a diabetic patient during an inpatient stay. Do not use Modifier 91 simply because testing equipment failed or a specimen was inadequate; in those cases, report the test once without the modifier when it is successfully re-run.

Example: A patient has TSH (84443) drawn at 8 AM and again at 2 PM on the same day due to suspicion of thyroid storm. Bill 84443 for the first draw and 84443-91 for the second.

Modifier 59 – Distinct Procedural Service

Use Modifier 59 (or its more specific X-modifiers: XE, XP, XS, XU) when a component test was performed as a distinctly separate service from the panel — for instance, if a CMP was ordered as part of a panel early in the day, and a separate glucose test (82947) was ordered later that same day for a different clinical reason. This modifier establishes that the second service is not a duplicate and has a distinct clinical purpose.

Modifier QW – CLIA-Waived Test

When a lab test is performed using a CLIA-waived testing device (e.g., a point-of-care glucose meter in the physician’s office), append Modifier QW to the applicable component code. This modifier does not apply to the panel code 80050 itself, but may apply to individual components billed separately when CLIA-waived methodology is used. The lab must hold an appropriate CLIA certificate.

Modifier AY – Unrelated to ESRD Treatment

As noted in the Medicare section, the AY modifier is appended to lab codes for ESRD patients on the PPS composite rate when the ordered test is unrelated to the patient’s ESRD management. This allows the individual test to be billed to Part B outside the composite rate. Without AY, the claim will be bundled and denied.

8. Audit-Proof Documentation Standards

Whether billing 80050 or its individual components, documentation must support the clinical rationale, the tests performed, and the diagnosis. Vague orders are among the most common audit triggers.

The Physician’s Order:

The order must clearly specify the tests requested. An order reading “run labs” or “check blood work” is insufficient. The order should specify either “General Health Panel (CMP + CBC with diff + TSH)” for 80050 or list each individual test by name or CPT code. Electronic requisitions are acceptable, but they must be clearly interpretable and retained in the medical record.

Screening vs. Diagnostic Documentation:

The record must unambiguously support whether each test is being ordered as a routine screen (in a patient with no relevant symptoms) or as a diagnostic test (in a patient with symptoms or a known condition). When a physician’s note simultaneously documents “routine annual physical” and “monitoring hypothyroidism,” the TSH component is diagnostic — it should be billed separately with E03.9, not bundled into 80050 as a screening test.

Results Reporting:

Lab results must be reported in the patient’s medical record with the ordering provider’s review documented. A lab report filed in the chart without any notation of physician review is a compliance weakness. Documentation should reflect that the provider reviewed the results and any clinical action taken (including “results within normal limits; no action required” as an explicit statement).

Time and Place of Service:

Ensure the Place of Service (POS) code on the claim matches where the blood was collected and analyzed. POS 11 (Office), POS 22 (On Campus Outpatient Hospital), POS 81 (Independent Laboratory), and POS 19 (Off Campus Outpatient Hospital) each have different billing implications and fee schedule rates.

9. Bundling Rules & NCCI Edits

The National Correct Coding Initiative (NCCI) edits establish specific rules for how laboratory panel codes interact with their component codes. These are among the most important compliance considerations for labs and physicians’ offices billing 80050 or related codes.

Panel Code Supremacy Rule:

When all components of a panel are billed on the same date of service by the same provider, the NCCI will automatically bundle the component codes into the panel code and pay only the panel. Conversely, if the panel code is submitted alongside one or more of its component codes, the claim will be denied or downcoded. Never bill both 80050 and 80053 (or 85025, or 84443) on the same claim for the same patient on the same day.

Overlapping Panels:

Because CPT 80053 (CMP) includes all the analytes in CPT 80048 (Basic Metabolic Panel), you cannot bill both 80048 and 80053 on the same date of service. Similarly, since 80048’s components are already in 80050, you cannot bill 80048 and 80050 together. If both are submitted, only the more comprehensive panel (80053 or 80050 depending on what was performed) will be reimbursed.

Greater Panel Rule:

AMA CPT guidelines instruct: “Do not report two or more Panel Codes that include any of the same constituent tests performed from the same patient collection. If a group of tests overlaps two or more panels, report the panel that incorporates the greater number of tests to fulfill the code definition and report the remaining tests using individual test codes.”

10. Panel Comparison: 80050 vs. 80053 vs. 80048

11. Real-World Clinical Scenarios

Scenario 1: Annual Physical — Commercial Insurance (Correct Use of 80050)

Patient: 45-year-old asymptomatic male, presenting for his annual wellness exam with a commercial insurer that covers CPT 80050 for routine preventive screenings.

Order: Physician orders “General Health Panel” — all three components (CMP, CBC with diff, TSH) are performed simultaneously from a single blood draw.

Diagnosis: Z00.00 (Encounter for general adult medical examination without abnormal findings).

Coding: 80050 — Z00.00.

Rationale: All three required components were performed together as a routine screen. The payer covers the bundled panel. Billing the panel code instead of three separate component codes is appropriate and preferred per AMA bundling guidelines.

Scenario 2: Medicare Patient — Incorrect Billing Corrected

Patient: 68-year-old Medicare beneficiary presenting for an annual wellness visit (G0439). Physician orders CMP, CBC with diff, and TSH.

Incorrect Billing: 80050 submitted — automatically denied.

Correct Billing: 80053 (CMP), 85025 (CBC with diff), 84443 (TSH) — each billed individually.

Diagnosis Linking: The CMP and CBC should be linked to a diagnostic ICD-10 code (e.g., E11.9 for diabetes monitoring, N18.3 for CKD stage 3) if medically indicated. The TSH may require E03.9 (hypothyroidism) or Z13.220 (thyroid screening). Without appropriate diagnostic codes, even these individual codes may be denied by Medicare as lacking medical necessity.

Rationale: Medicare does not cover 80050. Component codes billed individually with medical necessity diagnoses have the best chance of reimbursement.

Scenario 3: Pre-Employment Physical — Commercial Insurance

Patient: 28-year-old newly hired firefighter required to undergo pre-employment medical clearance. No complaints, no known diagnoses.

Order: Employer-mandated general health panel — all three components performed.

Diagnosis: Z02.1 (Encounter for pre-employment examination).

Coding: 80050 — Z02.1 (if payer covers) or 80053 + 85025 + 84443 — Z02.1 (if payer does not cover 80050).

Key Note: Many employer-sponsored health plans cover pre-employment panels differently from routine preventive panels. Verify coverage before billing. Some payers require the employer (not the health plan) to pay for pre-employment testing.

Scenario 4: Partial Panel Performed — Individual Component Billing Required

Patient: 55-year-old woman at annual visit. Physician orders CMP and CBC with diff but does not order TSH because the patient had a normal TSH drawn 6 months ago and the physician determines repeat testing is not clinically indicated.

Incorrect Billing: 80050 — would be fraudulent; TSH was never ordered or performed.

Correct Billing: 80053 (CMP) + 85025 (CBC with diff), each with appropriate diagnosis codes.

Rationale: 80050 requires ALL three components. Billing the panel when TSH was not performed constitutes a false claim. This is one of the most common compliance violations associated with 80050.

Scenario 5: Abnormal Findings Discovered During Screening Panel

Patient: 52-year-old woman at annual physical. 80050 is ordered and performed. Results return elevated TSH (8.5 mIU/L — consistent with hypothyroidism) and mildly elevated creatinine (1.4 mg/dL).

Initial Coding: 80050 — Z00.01 (Encounter for general adult medical examination with abnormal findings). Use Z00.01 (not Z00.00) because abnormal findings were identified.

Follow-Up Coding: The physician should add secondary diagnosis codes for the abnormal results: E03.9 (Hypothyroidism, unspecified) and R94.4 (Abnormal results of kidney function studies) or the more specific stage of CKD if documented.

Key Billing Note: The abnormal results from the screening panel do not change the 80050 panel billing for the initial encounter. However, if the physician subsequently orders a repeat TSH or creatinine for diagnostic purposes, those repeat tests are billed individually (84443, 82565) with diagnostic codes, not as a new 80050.

12. Denial Prevention & Appeals Strategy

Most Common Denial Reasons for CPT 80050

Providers routinely encounter the following denial reasons, each of which has a specific resolution strategy:

Denial: “Service Not Covered” (Medicare and select commercial payers).

Resolution: Do not appeal — rebill with individual component codes (80053, 85025, 84443) with appropriate medical necessity ICD-10 codes. Verify which tests were actually ordered and performed before rebilling.

Denial: “Not Medically Necessary” (Z00.00 paired with Medicare claim).

Resolution: Medicare does not recognize Z00.00 as a valid reason for lab coverage under traditional Medicare. Switch to a diagnostic ICD-10 code if the tests were clinically indicated, or issue an ABN retroactively if one was not obtained and the patient agrees to pay. Note: retroactive ABNs carry significant compliance risk.

Denial: “Duplicate Claim” or “Component Bundled into Panel”.

Resolution: Review the claim to ensure no component codes were billed alongside the 80050 panel code. Correct the claim by removing the duplicate component code(s) and resubmit with only the panel code (if payer accepts it) or only the component codes (if payer does not accept the panel).

Denial: “Frequency Limitation Exceeded”.

Resolution: Some payers limit how often certain lab components (especially TSH) can be covered per rolling 12-month period. Document the clinical rationale for the repeat testing in the medical record and include a letter of medical necessity with the appeal. Reference applicable clinical guidelines (e.g., ATA guidelines for thyroid monitoring).

Proactive Prevention Checklist:

Before submitting any 80050 claim, verify: (1) the payer accepts 80050 — call Provider Services or check the payer’s online policy portal; (2) all three required components were ordered and performed; (3) the diagnosis code supports the screening nature of the panel; (4) the claim does not include both the panel code and its component codes; and (5) an ABN was obtained if Medicare coverage is uncertain.